Hemodynamically significant patent ductus arteriosus and the development of bronchopulmonary dysplasia.
Kent A WillisMark F WeemsPublished in: Congenital heart disease (2018)
Patent ductus arteriosus (PDA) is prevalent in premature newborns and has been linked to the development of bronchopulmonary dysplasia (BPD), a serious pulmonary complication of premature birth. Although a causal relationship has not been proven, the link is greatest among infants born at lower gestational age who are treated with mechanical ventilation in the presence of a large ductal shunt. Despite strong association in epidemiological studies, treatment of a patent ductus arteriosus has not been shown to prevent BPD, and some therapies may increase the risk of BPD. We describe preclinical and clinical data demonstrating the association of a PDA with BPD, highlight the effects of surgical and pharmacological treatment, and explore the implications of recent clinical trials for the management of PDA in the premature newborn.
Keyphrases
- gestational age
- mechanical ventilation
- birth weight
- clinical trial
- preterm birth
- acute respiratory distress syndrome
- pulmonary hypertension
- pregnant women
- stem cells
- randomized controlled trial
- low birth weight
- intensive care unit
- machine learning
- bone marrow
- pulmonary artery
- mesenchymal stem cells
- study protocol
- open label
- preterm infants
- weight loss
- replacement therapy
- deep learning
- respiratory failure
- weight gain
- case control